nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0691	0.141	CbGbCtD
Triazolam—CYP3A7—Dexamethasone—psoriatic arthritis	0.0691	0.141	CbGbCtD
Triazolam—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0534	0.109	CbGbCtD
Triazolam—CYP3A5—Dexamethasone—psoriatic arthritis	0.0518	0.106	CbGbCtD
Triazolam—CYP2C8—Dexamethasone—psoriatic arthritis	0.0498	0.102	CbGbCtD
Triazolam—CYP3A4—Triamcinolone—psoriatic arthritis	0.0405	0.0826	CbGbCtD
Triazolam—CYP2C9—Dexamethasone—psoriatic arthritis	0.0348	0.0709	CbGbCtD
Triazolam—CYP3A4—Betamethasone—psoriatic arthritis	0.0347	0.0709	CbGbCtD
Triazolam—CYP3A4—Prednisolone—psoriatic arthritis	0.0343	0.0699	CbGbCtD
Triazolam—CYP3A4—Prednisone—psoriatic arthritis	0.0324	0.066	CbGbCtD
Triazolam—CYP3A4—Dexamethasone—psoriatic arthritis	0.0202	0.0412	CbGbCtD
Triazolam—Mood swings—Prednisolone—psoriatic arthritis	0.00246	0.00483	CcSEcCtD
Triazolam—Osteoarthritis—Triamcinolone—psoriatic arthritis	0.00239	0.00468	CcSEcCtD
Triazolam—Osteoarthritis—Methylprednisolone—psoriatic arthritis	0.00238	0.00467	CcSEcCtD
Triazolam—Nausea—Auranofin—psoriatic arthritis	0.00238	0.00466	CcSEcCtD
Triazolam—Glossitis—Methotrexate—psoriatic arthritis	0.00236	0.00462	CcSEcCtD
Triazolam—Affect lability—Triamcinolone—psoriatic arthritis	0.00235	0.00461	CcSEcCtD
Triazolam—Affect lability—Methylprednisolone—psoriatic arthritis	0.00235	0.0046	CcSEcCtD
Triazolam—Dysarthria—Methotrexate—psoriatic arthritis	0.0023	0.00451	CcSEcCtD
Triazolam—Muscular weakness—Prednisolone—psoriatic arthritis	0.00229	0.00449	CcSEcCtD
Triazolam—Visual disturbance—Betamethasone—psoriatic arthritis	0.00229	0.00449	CcSEcCtD
Triazolam—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00229	0.00449	CcSEcCtD
Triazolam—Irritability—Methylprednisolone—psoriatic arthritis	0.00227	0.00446	CcSEcCtD
Triazolam—Mood swings—Triamcinolone—psoriatic arthritis	0.00226	0.00444	CcSEcCtD
Triazolam—Mood swings—Methylprednisolone—psoriatic arthritis	0.00226	0.00443	CcSEcCtD
Triazolam—Euphoric mood—Prednisone—psoriatic arthritis	0.00223	0.00438	CcSEcCtD
Triazolam—Sweating increased—Prednisolone—psoriatic arthritis	0.00219	0.00429	CcSEcCtD
Triazolam—Osteoarthritis—Dexamethasone—psoriatic arthritis	0.00217	0.00425	CcSEcCtD
Triazolam—Osteoarthritis—Betamethasone—psoriatic arthritis	0.00217	0.00425	CcSEcCtD
Triazolam—Affect lability—Dexamethasone—psoriatic arthritis	0.00213	0.00418	CcSEcCtD
Triazolam—Affect lability—Betamethasone—psoriatic arthritis	0.00213	0.00418	CcSEcCtD
Triazolam—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00211	0.00413	CcSEcCtD
Triazolam—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.0021	0.00412	CcSEcCtD
Triazolam—Depressed level of consciousness—Methotrexate—psoriatic arthritis	0.0021	0.00412	CcSEcCtD
Triazolam—Irritability—Betamethasone—psoriatic arthritis	0.00207	0.00406	CcSEcCtD
Triazolam—Irritability—Dexamethasone—psoriatic arthritis	0.00207	0.00406	CcSEcCtD
Triazolam—Mood swings—Dexamethasone—psoriatic arthritis	0.00205	0.00403	CcSEcCtD
Triazolam—Mood swings—Betamethasone—psoriatic arthritis	0.00205	0.00403	CcSEcCtD
Triazolam—Sweating increased—Triamcinolone—psoriatic arthritis	0.00201	0.00394	CcSEcCtD
Triazolam—Amnesia—Prednisone—psoriatic arthritis	0.00201	0.00394	CcSEcCtD
Triazolam—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00201	0.00394	CcSEcCtD
Triazolam—Muscular weakness—Betamethasone—psoriatic arthritis	0.00191	0.00375	CcSEcCtD
Triazolam—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00191	0.00375	CcSEcCtD
Triazolam—Osteoarthritis—Prednisone—psoriatic arthritis	0.00189	0.0037	CcSEcCtD
Triazolam—Affect lability—Prednisone—psoriatic arthritis	0.00186	0.00364	CcSEcCtD
Triazolam—Sweating increased—Betamethasone—psoriatic arthritis	0.00182	0.00358	CcSEcCtD
Triazolam—Sweating increased—Dexamethasone—psoriatic arthritis	0.00182	0.00358	CcSEcCtD
Triazolam—Irritability—Prednisone—psoriatic arthritis	0.0018	0.00353	CcSEcCtD
Triazolam—Mood swings—Prednisone—psoriatic arthritis	0.00179	0.00351	CcSEcCtD
Triazolam—Hepatic failure—Methotrexate—psoriatic arthritis	0.00175	0.00344	CcSEcCtD
Triazolam—Visual impairment—Prednisolone—psoriatic arthritis	0.00173	0.0034	CcSEcCtD
Triazolam—Muscular weakness—Prednisone—psoriatic arthritis	0.00166	0.00326	CcSEcCtD
Triazolam—Visual disturbance—Methotrexate—psoriatic arthritis	0.00166	0.00326	CcSEcCtD
Triazolam—Hallucination—Methylprednisolone—psoriatic arthritis	0.00164	0.00322	CcSEcCtD
Triazolam—Sweating increased—Prednisone—psoriatic arthritis	0.00159	0.00312	CcSEcCtD
Triazolam—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00159	0.00312	CcSEcCtD
Triazolam—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00158	0.00309	CcSEcCtD
Triazolam—Erythema—Prednisolone—psoriatic arthritis	0.00156	0.00307	CcSEcCtD
Triazolam—Irritability—Methotrexate—psoriatic arthritis	0.00151	0.00295	CcSEcCtD
Triazolam—Mood swings—Methotrexate—psoriatic arthritis	0.00149	0.00293	CcSEcCtD
Triazolam—Hallucination—Dexamethasone—psoriatic arthritis	0.00149	0.00293	CcSEcCtD
Triazolam—Hallucination—Betamethasone—psoriatic arthritis	0.00149	0.00293	CcSEcCtD
Triazolam—Ataxia—Methotrexate—psoriatic arthritis	0.00148	0.00291	CcSEcCtD
Triazolam—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00145	0.00285	CcSEcCtD
Triazolam—Visual impairment—Betamethasone—psoriatic arthritis	0.00144	0.00283	CcSEcCtD
Triazolam—Visual impairment—Dexamethasone—psoriatic arthritis	0.00144	0.00283	CcSEcCtD
Triazolam—Erythema—Triamcinolone—psoriatic arthritis	0.00144	0.00282	CcSEcCtD
Triazolam—Erythema—Methylprednisolone—psoriatic arthritis	0.00144	0.00281	CcSEcCtD
Triazolam—Malaise—Prednisolone—psoriatic arthritis	0.00141	0.00277	CcSEcCtD
Triazolam—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00141	0.00276	CcSEcCtD
Triazolam—Syncope—Prednisolone—psoriatic arthritis	0.0014	0.00275	CcSEcCtD
Triazolam—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00137	0.0027	CcSEcCtD
Triazolam—Hypertension—Prednisolone—psoriatic arthritis	0.00135	0.00265	CcSEcCtD
Triazolam—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00133	0.00262	CcSEcCtD
Triazolam—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00133	0.00261	CcSEcCtD
Triazolam—Discomfort—Prednisolone—psoriatic arthritis	0.00132	0.00258	CcSEcCtD
Triazolam—Erythema—Betamethasone—psoriatic arthritis	0.0013	0.00256	CcSEcCtD
Triazolam—Erythema—Dexamethasone—psoriatic arthritis	0.0013	0.00256	CcSEcCtD
Triazolam—Hallucination—Prednisone—psoriatic arthritis	0.0013	0.00255	CcSEcCtD
Triazolam—Malaise—Triamcinolone—psoriatic arthritis	0.0013	0.00254	CcSEcCtD
Triazolam—Malaise—Methylprednisolone—psoriatic arthritis	0.00129	0.00254	CcSEcCtD
Triazolam—Syncope—Triamcinolone—psoriatic arthritis	0.00129	0.00253	CcSEcCtD
Triazolam—Syncope—Methylprednisolone—psoriatic arthritis	0.00129	0.00252	CcSEcCtD
Triazolam—Oedema—Prednisolone—psoriatic arthritis	0.00128	0.0025	CcSEcCtD
Triazolam—Dysuria—Methotrexate—psoriatic arthritis	0.00127	0.0025	CcSEcCtD
Triazolam—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00126	0.00248	CcSEcCtD
Triazolam—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00126	0.00247	CcSEcCtD
Triazolam—Shock—Prednisolone—psoriatic arthritis	0.00126	0.00246	CcSEcCtD
Triazolam—Tachycardia—Prednisolone—psoriatic arthritis	0.00125	0.00244	CcSEcCtD
Triazolam—Hypertension—Triamcinolone—psoriatic arthritis	0.00124	0.00244	CcSEcCtD
Triazolam—Hypertension—Methylprednisolone—psoriatic arthritis	0.00124	0.00243	CcSEcCtD
Triazolam—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00123	0.00242	CcSEcCtD
Triazolam—Anxiety—Methylprednisolone—psoriatic arthritis	0.00122	0.00239	CcSEcCtD
Triazolam—Drowsiness—Methotrexate—psoriatic arthritis	0.00122	0.00238	CcSEcCtD
Triazolam—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00121	0.00238	CcSEcCtD
Triazolam—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00121	0.00238	CcSEcCtD
Triazolam—Discomfort—Triamcinolone—psoriatic arthritis	0.00121	0.00237	CcSEcCtD
Triazolam—Discomfort—Methylprednisolone—psoriatic arthritis	0.00121	0.00237	CcSEcCtD
Triazolam—Dry mouth—Triamcinolone—psoriatic arthritis	0.0012	0.00235	CcSEcCtD
Triazolam—Stomatitis—Methotrexate—psoriatic arthritis	0.00118	0.00232	CcSEcCtD
Triazolam—Confusional state—Methylprednisolone—psoriatic arthritis	0.00118	0.00232	CcSEcCtD
Triazolam—Malaise—Betamethasone—psoriatic arthritis	0.00118	0.00231	CcSEcCtD
Triazolam—Malaise—Dexamethasone—psoriatic arthritis	0.00118	0.00231	CcSEcCtD
Triazolam—Oedema—Triamcinolone—psoriatic arthritis	0.00117	0.0023	CcSEcCtD
Triazolam—Syncope—Dexamethasone—psoriatic arthritis	0.00117	0.0023	CcSEcCtD
Triazolam—Syncope—Betamethasone—psoriatic arthritis	0.00117	0.0023	CcSEcCtD
Triazolam—Shock—Triamcinolone—psoriatic arthritis	0.00115	0.00227	CcSEcCtD
Triazolam—Insomnia—Prednisolone—psoriatic arthritis	0.00115	0.00226	CcSEcCtD
Triazolam—Shock—Methylprednisolone—psoriatic arthritis	0.00115	0.00226	CcSEcCtD
Triazolam—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00115	0.00225	CcSEcCtD
Triazolam—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00115	0.00225	CcSEcCtD
Triazolam—Paraesthesia—Prednisolone—psoriatic arthritis	0.00115	0.00225	CcSEcCtD
Triazolam—Tachycardia—Triamcinolone—psoriatic arthritis	0.00115	0.00225	CcSEcCtD
Triazolam—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00114	0.00224	CcSEcCtD
Triazolam—Erythema—Prednisone—psoriatic arthritis	0.00114	0.00223	CcSEcCtD
Triazolam—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00113	0.00223	CcSEcCtD
Triazolam—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00113	0.00222	CcSEcCtD
Triazolam—Hypertension—Dexamethasone—psoriatic arthritis	0.00113	0.00221	CcSEcCtD
Triazolam—Hypertension—Betamethasone—psoriatic arthritis	0.00113	0.00221	CcSEcCtD
Triazolam—Anxiety—Dexamethasone—psoriatic arthritis	0.00111	0.00217	CcSEcCtD
Triazolam—Anxiety—Betamethasone—psoriatic arthritis	0.00111	0.00217	CcSEcCtD
Triazolam—Discomfort—Betamethasone—psoriatic arthritis	0.0011	0.00215	CcSEcCtD
Triazolam—Discomfort—Dexamethasone—psoriatic arthritis	0.0011	0.00215	CcSEcCtD
Triazolam—Pain—Prednisolone—psoriatic arthritis	0.00109	0.00214	CcSEcCtD
Triazolam—Oedema—Dexamethasone—psoriatic arthritis	0.00107	0.00209	CcSEcCtD
Triazolam—Oedema—Betamethasone—psoriatic arthritis	0.00107	0.00209	CcSEcCtD
Triazolam—Insomnia—Triamcinolone—psoriatic arthritis	0.00106	0.00208	CcSEcCtD
Triazolam—Insomnia—Methylprednisolone—psoriatic arthritis	0.00106	0.00208	CcSEcCtD
Triazolam—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00105	0.00207	CcSEcCtD
Triazolam—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00105	0.00207	CcSEcCtD
Triazolam—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00105	0.00206	CcSEcCtD
Triazolam—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00105	0.00206	CcSEcCtD
Triazolam—Visual impairment—Methotrexate—psoriatic arthritis	0.00105	0.00206	CcSEcCtD
Triazolam—Shock—Dexamethasone—psoriatic arthritis	0.00105	0.00206	CcSEcCtD
Triazolam—Shock—Betamethasone—psoriatic arthritis	0.00105	0.00206	CcSEcCtD
Triazolam—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00105	0.00205	CcSEcCtD
Triazolam—Agitation—Prednisone—psoriatic arthritis	0.00104	0.00205	CcSEcCtD
Triazolam—Tachycardia—Betamethasone—psoriatic arthritis	0.00104	0.00204	CcSEcCtD
Triazolam—Tachycardia—Dexamethasone—psoriatic arthritis	0.00104	0.00204	CcSEcCtD
Triazolam—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00103	0.00202	CcSEcCtD
Triazolam—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00103	0.00202	CcSEcCtD
Triazolam—Malaise—Prednisone—psoriatic arthritis	0.00102	0.00201	CcSEcCtD
Triazolam—Syncope—Prednisone—psoriatic arthritis	0.00102	0.002	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—psoriatic arthritis	0.00102	0.002	CcSEcCtD
Triazolam—Anorexia—Betamethasone—psoriatic arthritis	0.00102	0.00199	CcSEcCtD
Triazolam—Anorexia—Dexamethasone—psoriatic arthritis	0.00102	0.00199	CcSEcCtD
Triazolam—Fatigue—Triamcinolone—psoriatic arthritis	0.00101	0.00199	CcSEcCtD
Triazolam—Fatigue—Methylprednisolone—psoriatic arthritis	0.00101	0.00198	CcSEcCtD
Triazolam—Pain—Triamcinolone—psoriatic arthritis	0.001	0.00197	CcSEcCtD
Triazolam—Loss of consciousness—Prednisone—psoriatic arthritis	0.000999	0.00196	CcSEcCtD
Triazolam—Hypertension—Prednisone—psoriatic arthritis	0.000981	0.00192	CcSEcCtD
Triazolam—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000967	0.0019	CcSEcCtD
Triazolam—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000965	0.00189	CcSEcCtD
Triazolam—Anxiety—Prednisone—psoriatic arthritis	0.000964	0.00189	CcSEcCtD
Triazolam—Insomnia—Dexamethasone—psoriatic arthritis	0.000963	0.00189	CcSEcCtD
Triazolam—Insomnia—Betamethasone—psoriatic arthritis	0.000963	0.00189	CcSEcCtD
Triazolam—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000958	0.00188	CcSEcCtD
Triazolam—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000956	0.00188	CcSEcCtD
Triazolam—Paraesthesia—Betamethasone—psoriatic arthritis	0.000956	0.00188	CcSEcCtD
Triazolam—Discomfort—Prednisone—psoriatic arthritis	0.000956	0.00188	CcSEcCtD
Triazolam—Erythema—Methotrexate—psoriatic arthritis	0.00095	0.00186	CcSEcCtD
Triazolam—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00094	0.00184	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—psoriatic arthritis	0.00093	0.00182	CcSEcCtD
Triazolam—Oedema—Prednisone—psoriatic arthritis	0.000928	0.00182	CcSEcCtD
Triazolam—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000926	0.00182	CcSEcCtD
Triazolam—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000926	0.00182	CcSEcCtD
Triazolam—Decreased appetite—Betamethasone—psoriatic arthritis	0.000926	0.00182	CcSEcCtD
Triazolam—Fatigue—Betamethasone—psoriatic arthritis	0.000918	0.0018	CcSEcCtD
Triazolam—Fatigue—Dexamethasone—psoriatic arthritis	0.000918	0.0018	CcSEcCtD
Triazolam—Shock—Prednisone—psoriatic arthritis	0.000913	0.00179	CcSEcCtD
Triazolam—Pain—Dexamethasone—psoriatic arthritis	0.000911	0.00179	CcSEcCtD
Triazolam—Pain—Betamethasone—psoriatic arthritis	0.000911	0.00179	CcSEcCtD
Triazolam—Tachycardia—Prednisone—psoriatic arthritis	0.000905	0.00178	CcSEcCtD
Triazolam—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000897	0.00176	CcSEcCtD
Triazolam—Anorexia—Prednisone—psoriatic arthritis	0.000884	0.00173	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000881	0.00173	CcSEcCtD
Triazolam—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000878	0.00172	CcSEcCtD
Triazolam—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000878	0.00172	CcSEcCtD
Triazolam—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000871	0.00171	CcSEcCtD
Triazolam—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000871	0.00171	CcSEcCtD
Triazolam—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000865	0.0017	CcSEcCtD
Triazolam—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000863	0.00169	CcSEcCtD
Triazolam—Malaise—Methotrexate—psoriatic arthritis	0.000857	0.00168	CcSEcCtD
Triazolam—Dizziness—Prednisolone—psoriatic arthritis	0.000844	0.00166	CcSEcCtD
Triazolam—Asthenia—Triamcinolone—psoriatic arthritis	0.000842	0.00165	CcSEcCtD
Triazolam—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000842	0.00165	CcSEcCtD
Triazolam—Abdominal pain—Betamethasone—psoriatic arthritis	0.000842	0.00165	CcSEcCtD
Triazolam—Asthenia—Methylprednisolone—psoriatic arthritis	0.00084	0.00165	CcSEcCtD
Triazolam—Insomnia—Prednisone—psoriatic arthritis	0.000839	0.00165	CcSEcCtD
Triazolam—Paraesthesia—Prednisone—psoriatic arthritis	0.000833	0.00163	CcSEcCtD
Triazolam—Pruritus—Triamcinolone—psoriatic arthritis	0.00083	0.00163	CcSEcCtD
Triazolam—Pruritus—Methylprednisolone—psoriatic arthritis	0.000829	0.00163	CcSEcCtD
Triazolam—Chest pain—Methotrexate—psoriatic arthritis	0.000809	0.00159	CcSEcCtD
Triazolam—Decreased appetite—Prednisone—psoriatic arthritis	0.000806	0.00158	CcSEcCtD
Triazolam—Dermatitis—Prednisolone—psoriatic arthritis	0.000804	0.00158	CcSEcCtD
Triazolam—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000801	0.00157	CcSEcCtD
Triazolam—Fatigue—Prednisone—psoriatic arthritis	0.0008	0.00157	CcSEcCtD
Triazolam—Headache—Prednisolone—psoriatic arthritis	0.0008	0.00157	CcSEcCtD
Triazolam—Discomfort—Methotrexate—psoriatic arthritis	0.000799	0.00157	CcSEcCtD
Triazolam—Constipation—Prednisone—psoriatic arthritis	0.000793	0.00156	CcSEcCtD
Triazolam—Confusional state—Methotrexate—psoriatic arthritis	0.000782	0.00153	CcSEcCtD
Triazolam—Dizziness—Triamcinolone—psoriatic arthritis	0.000776	0.00152	CcSEcCtD
Triazolam—Dizziness—Methylprednisolone—psoriatic arthritis	0.000774	0.00152	CcSEcCtD
Triazolam—Feeling abnormal—Prednisone—psoriatic arthritis	0.000764	0.0015	CcSEcCtD
Triazolam—Asthenia—Dexamethasone—psoriatic arthritis	0.000764	0.0015	CcSEcCtD
Triazolam—Asthenia—Betamethasone—psoriatic arthritis	0.000764	0.0015	CcSEcCtD
Triazolam—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000758	0.00149	CcSEcCtD
Triazolam—Nausea—Prednisolone—psoriatic arthritis	0.000758	0.00149	CcSEcCtD
Triazolam—Pruritus—Betamethasone—psoriatic arthritis	0.000754	0.00148	CcSEcCtD
Triazolam—Pruritus—Dexamethasone—psoriatic arthritis	0.000754	0.00148	CcSEcCtD
Triazolam—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000749	0.00147	CcSEcCtD
Triazolam—Vomiting—Triamcinolone—psoriatic arthritis	0.000746	0.00146	CcSEcCtD
Triazolam—Vomiting—Methylprednisolone—psoriatic arthritis	0.000745	0.00146	CcSEcCtD
Triazolam—Dermatitis—Triamcinolone—psoriatic arthritis	0.000739	0.00145	CcSEcCtD
Triazolam—Anorexia—Methotrexate—psoriatic arthritis	0.000739	0.00145	CcSEcCtD
Triazolam—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000738	0.00145	CcSEcCtD
Triazolam—Headache—Triamcinolone—psoriatic arthritis	0.000735	0.00144	CcSEcCtD
Triazolam—Headache—Methylprednisolone—psoriatic arthritis	0.000734	0.00144	CcSEcCtD
Triazolam—Abdominal pain—Prednisone—psoriatic arthritis	0.000733	0.00144	CcSEcCtD
Triazolam—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000729	0.00143	CcSEcCtD
Triazolam—Diarrhoea—Betamethasone—psoriatic arthritis	0.000729	0.00143	CcSEcCtD
Triazolam—Dizziness—Betamethasone—psoriatic arthritis	0.000704	0.00138	CcSEcCtD
Triazolam—Dizziness—Dexamethasone—psoriatic arthritis	0.000704	0.00138	CcSEcCtD
Triazolam—Insomnia—Methotrexate—psoriatic arthritis	0.000701	0.00138	CcSEcCtD
Triazolam—Nausea—Triamcinolone—psoriatic arthritis	0.000697	0.00137	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—psoriatic arthritis	0.000696	0.00137	CcSEcCtD
Triazolam—Nausea—Methylprednisolone—psoriatic arthritis	0.000696	0.00136	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—psoriatic arthritis	0.000691	0.00136	CcSEcCtD
Triazolam—Somnolence—Methotrexate—psoriatic arthritis	0.000689	0.00135	CcSEcCtD
Triazolam—Hypersensitivity—Prednisone—psoriatic arthritis	0.000683	0.00134	CcSEcCtD
Triazolam—Vomiting—Betamethasone—psoriatic arthritis	0.000677	0.00133	CcSEcCtD
Triazolam—Vomiting—Dexamethasone—psoriatic arthritis	0.000677	0.00133	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—psoriatic arthritis	0.000674	0.00132	CcSEcCtD
Triazolam—Dermatitis—Betamethasone—psoriatic arthritis	0.000671	0.00132	CcSEcCtD
Triazolam—Dermatitis—Dexamethasone—psoriatic arthritis	0.000671	0.00132	CcSEcCtD
Triazolam—Fatigue—Methotrexate—psoriatic arthritis	0.000668	0.00131	CcSEcCtD
Triazolam—Headache—Betamethasone—psoriatic arthritis	0.000667	0.00131	CcSEcCtD
Triazolam—Headache—Dexamethasone—psoriatic arthritis	0.000667	0.00131	CcSEcCtD
Triazolam—Asthenia—Prednisone—psoriatic arthritis	0.000665	0.00131	CcSEcCtD
Triazolam—Pain—Methotrexate—psoriatic arthritis	0.000663	0.0013	CcSEcCtD
Triazolam—Pruritus—Prednisone—psoriatic arthritis	0.000656	0.00129	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000639	0.00125	CcSEcCtD
Triazolam—Diarrhoea—Prednisone—psoriatic arthritis	0.000635	0.00124	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000634	0.00124	CcSEcCtD
Triazolam—Nausea—Betamethasone—psoriatic arthritis	0.000633	0.00124	CcSEcCtD
Triazolam—Nausea—Dexamethasone—psoriatic arthritis	0.000633	0.00124	CcSEcCtD
Triazolam—Dizziness—Prednisone—psoriatic arthritis	0.000613	0.0012	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—psoriatic arthritis	0.000613	0.0012	CcSEcCtD
Triazolam—Vomiting—Prednisone—psoriatic arthritis	0.00059	0.00116	CcSEcCtD
Triazolam—Dermatitis—Prednisone—psoriatic arthritis	0.000584	0.00115	CcSEcCtD
Triazolam—Headache—Prednisone—psoriatic arthritis	0.000581	0.00114	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000571	0.00112	CcSEcCtD
Triazolam—Asthenia—Methotrexate—psoriatic arthritis	0.000556	0.00109	CcSEcCtD
Triazolam—Nausea—Prednisone—psoriatic arthritis	0.000551	0.00108	CcSEcCtD
Triazolam—Pruritus—Methotrexate—psoriatic arthritis	0.000548	0.00108	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—psoriatic arthritis	0.00053	0.00104	CcSEcCtD
Triazolam—Dizziness—Methotrexate—psoriatic arthritis	0.000513	0.00101	CcSEcCtD
Triazolam—Vomiting—Methotrexate—psoriatic arthritis	0.000493	0.000967	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—psoriatic arthritis	0.000488	0.000958	CcSEcCtD
Triazolam—Headache—Methotrexate—psoriatic arthritis	0.000486	0.000953	CcSEcCtD
Triazolam—Nausea—Methotrexate—psoriatic arthritis	0.00046	0.000903	CcSEcCtD
